IBDEI0D9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6327,1,4,0)
 ;;=4^HYPERALDOSTERONISM
 ;;^UTILITY(U,$J,358.3,6327,1,5,0)
 ;;=5^255.10
 ;;^UTILITY(U,$J,358.3,6327,2)
 ;;=^330019
 ;;^UTILITY(U,$J,358.3,6328,0)
 ;;=227.0^^44^509^16
 ;;^UTILITY(U,$J,358.3,6328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6328,1,4,0)
 ;;=4^PHEOCHROMOCYTOMA,BENIGN
 ;;^UTILITY(U,$J,358.3,6328,1,5,0)
 ;;=5^227.0
 ;;^UTILITY(U,$J,358.3,6328,2)
 ;;=^267688
 ;;^UTILITY(U,$J,358.3,6329,0)
 ;;=255.12^^44^509^8
 ;;^UTILITY(U,$J,358.3,6329,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6329,1,4,0)
 ;;=4^CONN'S SYNDROME
 ;;^UTILITY(U,$J,358.3,6329,1,5,0)
 ;;=5^255.12
 ;;^UTILITY(U,$J,358.3,6329,2)
 ;;=^329905
 ;;^UTILITY(U,$J,358.3,6330,0)
 ;;=266.2^^44^509^7
 ;;^UTILITY(U,$J,358.3,6330,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6330,1,4,0)
 ;;=4^B-COMPLEX DEFIC NEC
 ;;^UTILITY(U,$J,358.3,6330,1,5,0)
 ;;=5^266.2
 ;;^UTILITY(U,$J,358.3,6330,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,6331,0)
 ;;=255.0^^44^509^9
 ;;^UTILITY(U,$J,358.3,6331,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6331,1,4,0)
 ;;=4^CUSHING'S SYNDROME
 ;;^UTILITY(U,$J,358.3,6331,1,5,0)
 ;;=5^255.0
 ;;^UTILITY(U,$J,358.3,6331,2)
 ;;=^29802
 ;;^UTILITY(U,$J,358.3,6332,0)
 ;;=255.41^^44^509^11
 ;;^UTILITY(U,$J,358.3,6332,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6332,1,4,0)
 ;;=4^GLUCOCORTICOID DEFICIENT
 ;;^UTILITY(U,$J,358.3,6332,1,5,0)
 ;;=5^255.41
 ;;^UTILITY(U,$J,358.3,6332,2)
 ;;=^335240
 ;;^UTILITY(U,$J,358.3,6333,0)
 ;;=255.42^^44^509^15
 ;;^UTILITY(U,$J,358.3,6333,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6333,1,4,0)
 ;;=4^MINERALCORTICOID DEFCNT
 ;;^UTILITY(U,$J,358.3,6333,1,5,0)
 ;;=5^255.42
 ;;^UTILITY(U,$J,358.3,6333,2)
 ;;=^335241
 ;;^UTILITY(U,$J,358.3,6334,0)
 ;;=790.6^^44^509^1
 ;;^UTILITY(U,$J,358.3,6334,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6334,1,4,0)
 ;;=4^ABN BLOOD CHEMISTRY NEC
 ;;^UTILITY(U,$J,358.3,6334,1,5,0)
 ;;=5^790.6
 ;;^UTILITY(U,$J,358.3,6334,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,6335,0)
 ;;=274.9^^44^509^12
 ;;^UTILITY(U,$J,358.3,6335,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6335,1,4,0)
 ;;=4^GOUT NOS
 ;;^UTILITY(U,$J,358.3,6335,1,5,0)
 ;;=5^274.9
 ;;^UTILITY(U,$J,358.3,6335,2)
 ;;=^52625
 ;;^UTILITY(U,$J,358.3,6336,0)
 ;;=239.7^^44^509^10
 ;;^UTILITY(U,$J,358.3,6336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6336,1,4,0)
 ;;=4^ENDOCRINE/NERV NEO NOS
 ;;^UTILITY(U,$J,358.3,6336,1,5,0)
 ;;=5^239.7
 ;;^UTILITY(U,$J,358.3,6336,2)
 ;;=^267785
 ;;^UTILITY(U,$J,358.3,6337,0)
 ;;=255.8^^44^509^2
 ;;^UTILITY(U,$J,358.3,6337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6337,1,4,0)
 ;;=4^ADRENAL DISORDER NEC
 ;;^UTILITY(U,$J,358.3,6337,1,5,0)
 ;;=5^255.8
 ;;^UTILITY(U,$J,358.3,6337,2)
 ;;=^267874
 ;;^UTILITY(U,$J,358.3,6338,0)
 ;;=255.2^^44^509^4
 ;;^UTILITY(U,$J,358.3,6338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6338,1,4,0)
 ;;=4^ADRENOGENITAL DISORDERS
 ;;^UTILITY(U,$J,358.3,6338,1,5,0)
 ;;=5^255.2
 ;;^UTILITY(U,$J,358.3,6338,2)
 ;;=^3796
 ;;^UTILITY(U,$J,358.3,6339,0)
 ;;=V15.3^^44^509^13
 ;;^UTILITY(U,$J,358.3,6339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6339,1,4,0)
 ;;=4^HX OF IRRADIATION
 ;;^UTILITY(U,$J,358.3,6339,1,5,0)
 ;;=5^V15.3
 ;;^UTILITY(U,$J,358.3,6339,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,6340,0)
 ;;=733.00^^44^510^8
 ;;^UTILITY(U,$J,358.3,6340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6340,1,4,0)
 ;;=4^OSTEOPOROSIS NOS
 ;;^UTILITY(U,$J,358.3,6340,1,5,0)
 ;;=5^733.00
 ;;^UTILITY(U,$J,358.3,6340,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,6341,0)
 ;;=733.01^^44^510^12
 ;;^UTILITY(U,$J,358.3,6341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6341,1,4,0)
 ;;=4^OSTEOPOROSIS,SENILE
